| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80053 |
Comprehensive metabolic panel |
10,950 |
8,187 |
$670K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
4,911 |
1,613 |
$441K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,251 |
5,785 |
$392K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,319 |
1,364 |
$280K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,478 |
12,614 |
$246K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,776 |
3,100 |
$157K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
954 |
714 |
$121K |
| 81001 |
|
12,014 |
9,322 |
$110K |
| 36415 |
Collection of venous blood by venipuncture |
1,084 |
796 |
$105K |
| 87081 |
|
2,035 |
1,753 |
$104K |
| 87275 |
|
3,197 |
2,667 |
$104K |
| 84702 |
|
1,659 |
1,256 |
$96K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,603 |
510 |
$82K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
14,143 |
11,099 |
$74K |
| 87210 |
|
796 |
704 |
$58K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
347 |
272 |
$55K |
| 71046 |
Radiologic examination, chest; 2 views |
4,288 |
3,446 |
$55K |
| 82565 |
|
378 |
241 |
$53K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
35 |
12 |
$52K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
236 |
193 |
$51K |
| 81002 |
|
350 |
263 |
$50K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,092 |
2,519 |
$48K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,570 |
2,763 |
$45K |
| 87070 |
|
290 |
193 |
$43K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,223 |
1,013 |
$41K |
| 80047 |
|
631 |
467 |
$41K |
| 93971 |
|
669 |
520 |
$37K |
| 81025 |
|
5,704 |
4,651 |
$36K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,757 |
2,243 |
$25K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,770 |
2,229 |
$22K |
| 73562 |
|
1,034 |
756 |
$22K |
| 73630 |
|
717 |
547 |
$20K |
| 76801 |
|
1,122 |
919 |
$19K |
| 72100 |
|
974 |
725 |
$15K |
| 85027 |
|
19,624 |
13,570 |
$14K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
909 |
779 |
$13K |
| 73610 |
|
490 |
381 |
$13K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,098 |
967 |
$13K |
| 73030 |
|
690 |
520 |
$13K |
| A9270 |
Non-covered item or service |
13,933 |
3,750 |
$12K |
| 73130 |
|
451 |
366 |
$12K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
738 |
623 |
$11K |
| 74019 |
|
277 |
226 |
$10K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
952 |
727 |
$10K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
930 |
650 |
$10K |
| 87077 |
|
923 |
689 |
$10K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,632 |
6,076 |
$9K |
| 80076 |
|
615 |
497 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
5,579 |
4,155 |
$9K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
484 |
411 |
$9K |
| 72050 |
|
261 |
178 |
$9K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
136 |
108 |
$9K |
| 10060 |
|
71 |
57 |
$9K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,145 |
2,427 |
$8K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
624 |
504 |
$8K |
| 74018 |
|
238 |
188 |
$8K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
88 |
73 |
$7K |
| 73110 |
|
245 |
192 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,411 |
1,120 |
$6K |
| 77336 |
|
253 |
68 |
$6K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
790 |
663 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,946 |
1,699 |
$6K |
| 85610 |
|
3,267 |
2,427 |
$6K |
| 84484 |
|
7,912 |
5,018 |
$6K |
| 86850 |
|
808 |
603 |
$5K |
| 81003 |
|
748 |
620 |
$5K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
50 |
42 |
$4K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
271 |
244 |
$4K |
| 11045 |
|
730 |
185 |
$4K |
| 73502 |
|
254 |
186 |
$3K |
| 71250 |
|
22 |
12 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,834 |
6,679 |
$3K |
| 72072 |
|
194 |
156 |
$3K |
| 84703 |
|
470 |
416 |
$2K |
| 83605 |
|
2,244 |
1,553 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,370 |
1,081 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
74 |
65 |
$2K |
| 76642 |
|
143 |
107 |
$2K |
| 12011 |
|
15 |
13 |
$2K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
139 |
50 |
$1K |
| 84439 |
|
382 |
292 |
$1K |
| 93922 |
|
12 |
12 |
$1K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
12 |
12 |
$1K |
| 86900 |
|
1,431 |
1,125 |
$1K |
| 76830 |
Ultrasound, transvaginal |
59 |
51 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
19 |
18 |
$1K |
| 36600 |
|
15 |
12 |
$1K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
373 |
251 |
$1K |
| 76770 |
|
31 |
24 |
$999.18 |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,724 |
1,432 |
$989.47 |
| 73080 |
|
56 |
54 |
$953.92 |
| 87420 |
|
120 |
104 |
$895.87 |
| 73590 |
|
48 |
40 |
$891.64 |
| 77066 |
Tomosynthesis, mammo |
17 |
15 |
$814.97 |
| 86592 |
|
110 |
94 |
$746.20 |
| 80061 |
Lipid panel |
921 |
780 |
$729.81 |
| 77065 |
Tomosynthesis, mammo |
35 |
24 |
$724.92 |
| 85651 |
|
271 |
197 |
$716.37 |
| 82607 |
|
48 |
39 |
$672.04 |
| 82247 |
|
49 |
40 |
$631.53 |
| 85379 |
|
880 |
750 |
$548.09 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,266 |
893 |
$499.10 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
107 |
87 |
$467.28 |
| 73140 |
|
17 |
12 |
$387.86 |
| 83880 |
|
2,492 |
1,864 |
$331.49 |
| J2704 |
Injection, propofol, 10 mg |
1,446 |
1,050 |
$227.19 |
| 87147 |
|
779 |
569 |
$220.07 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
35 |
25 |
$213.23 |
| 87040 |
|
1,399 |
775 |
$213.09 |
| 86701 |
|
40 |
34 |
$193.48 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,582 |
1,190 |
$185.77 |
| 86780 |
|
29 |
24 |
$175.64 |
| 36000 |
|
251 |
201 |
$132.87 |
| 82550 |
|
892 |
717 |
$122.95 |
| 87205 |
|
491 |
329 |
$118.42 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
44 |
38 |
$113.22 |
| 82728 |
|
14 |
12 |
$107.16 |
| 29125 |
|
13 |
12 |
$90.92 |
| 86141 |
|
137 |
99 |
$79.54 |
| 97597 |
|
60 |
25 |
$39.27 |
| 80164 |
|
165 |
108 |
$29.44 |
| 83735 |
|
2,635 |
1,672 |
$5.24 |
| 84132 |
|
108 |
85 |
$4.16 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,286 |
907 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
6,019 |
4,296 |
$0.00 |
| 87186 |
|
925 |
692 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,474 |
2,692 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
382 |
271 |
$0.00 |
| 90714 |
|
368 |
274 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,230 |
3,228 |
$0.00 |
| 84100 |
|
886 |
501 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,805 |
1,355 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,066 |
747 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
468 |
375 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
889 |
389 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
86 |
37 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
750 |
564 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
196 |
181 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
310 |
167 |
$0.00 |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
28 |
13 |
$0.00 |
| 85046 |
|
29 |
25 |
$0.00 |
| 93017 |
|
271 |
244 |
$0.00 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
108 |
63 |
$0.00 |
| J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
28 |
24 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
136 |
84 |
$0.00 |
| 93970 |
|
14 |
12 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
57 |
52 |
$0.00 |
| 82310 |
|
17 |
15 |
$0.00 |
| A6212 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
75 |
61 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
17 |
15 |
$0.00 |
| 86703 |
|
124 |
103 |
$0.00 |
| 82248 |
|
29 |
26 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
18 |
16 |
$0.00 |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
35 |
12 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
65 |
43 |
$0.00 |
| 85007 |
|
17 |
13 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,097 |
966 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
775 |
510 |
$0.00 |
| 85730 |
|
2,672 |
1,989 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,992 |
1,414 |
$0.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,294 |
2,516 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,085 |
2,758 |
$0.00 |
| 96376 |
|
392 |
296 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,888 |
1,173 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
232 |
172 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
571 |
460 |
$0.00 |
| G0378 |
Hospital observation service, per hour |
1,631 |
1,185 |
$0.00 |
| 83690 |
|
4,245 |
3,367 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
289 |
262 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,655 |
1,340 |
$0.00 |
| 82553 |
|
403 |
312 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,037 |
678 |
$0.00 |
| 87276 |
|
3,195 |
2,668 |
$0.00 |
| 82330 |
|
319 |
256 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
696 |
553 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,041 |
2,167 |
$0.00 |
| 88342 |
|
17 |
13 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
521 |
328 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
96 |
67 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
1,157 |
509 |
$0.00 |
| 86901 |
|
1,431 |
1,125 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
168 |
151 |
$0.00 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
63 |
53 |
$0.00 |
| 82150 |
|
14 |
14 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
488 |
368 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
44 |
39 |
$0.00 |
| 97162 |
|
72 |
65 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
105 |
78 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
80 |
71 |
$0.00 |
| 86762 |
|
38 |
34 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
472 |
305 |
$0.00 |
| C1769 |
Guide wire |
324 |
229 |
$0.00 |
| 87340 |
|
40 |
36 |
$0.00 |
| 70496 |
|
27 |
24 |
$0.00 |
| 86140 |
|
15 |
14 |
$0.00 |
| J3490 |
Unclassified drugs |
73 |
54 |
$0.00 |
| 70486 |
|
26 |
24 |
$0.00 |
| 70498 |
|
16 |
13 |
$0.00 |
| 82803 |
|
16 |
12 |
$0.00 |
| 74022 |
|
15 |
15 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
13 |
12 |
$0.00 |
| 86920 |
|
19 |
12 |
$0.00 |
| 85018 |
|
35 |
26 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
23 |
13 |
$0.00 |
| 73090 |
|
22 |
14 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
16 |
14 |
$0.00 |